Consistent with our analysis, GABARAPL1 and 2 activity was processed by ATG4B, whereas the ATG8 family except GABARAPL1 was inhibited by the inactivity of ATG4B, resulting in neurotoxicity induced by hyperglycemia [34]. The gene discussed is GABARAPL2; the disease is Hyperglycemia.